POST-USTEKINUMAB INDUCTION IL-12, IL-23, AND USTEKINUMAB LEVELS ARE ASSOCIATED WITH CLINICAL RESPONSE IN A MULTICENTRE PROSPECTIVE COHORT STUDY OF CROHN'S DISEASE PATIENTS: RESULTS FROM THE AURORA STUDY

被引：0
|
作者：
An, Yoon-Kyo
Lindsay, Niamh
Allan, Natalie
Khoo, Emi
Fernandes, Richard
Amiss, Anna
Hai Pham
Wong, Kam Fai
Ooi, Soong-Yuan
Thin, Lena
Lightowler, Daniel
Connor, Susan J.
Williams, Astrid-Jane
De Cruz, Peter
Suen, Christopher Li Wai
Kariyawasam, Viraj C.
Mitrev, Nikola
Ghaly, Simon
Andrews, Jane M.
Christensen, Britt
Sparrow, Miles
White, Lauren S.
Bryant, Robert V.
Ding, Nik S.
Leong, Rupert
Van Langenberg, Daniel R.
Seltenreich, Hansjoerg
Subramaniam, Kavitha
Radford-Smith, Graham L.
Begun, Jakob
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1749
引用
收藏
页码：S1108 / S1108
页数：1
相关论文
共 50 条
  • [21] Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn's Disease: A Retrospective Cohort Study
    Ito, Takahiro
    Maemoto, Atsuo
    Katsurada, Takehiko
    Tanaka, Hiroki
    Motoya, Satoshi
    Ueno, Nobuhiro
    Fujiya, Mikihiro
    Ashida, Toshifumi
    Hirayama, Daisuke
    Nakase, Hiroshi
    CROHNS & COLITIS 360, 2020, 2 (04) : 1 - 9
  • [22] Baseline clinical, hormonal and molecular markers associated with clinical response to IL-23 antagonism in hidradenitis suppurativa: A prospective cohort study
    Flora, A.
    Kozera, E. K.
    Jepsen, R.
    Gill, K.
    Xu, J.
    Frew, J. W.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (06) : 869 - 877
  • [23] Induction and maintenance of mucosal healing in Crohn's disease with ustekinumab in clinical practice - Results of a nationwide, prospective, multicenter study in Germany (MUCUS)
    Baumgart, D. C.
    Stallmach, A.
    Schubert, A.
    Howaldt, S.
    von Arnim, U.
    Ochsenkuehn, T.
    Stein, J.
    Luegering, A.
    Schmidt, D.
    Schulz, M.
    Fischer, A.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 669 - 670
  • [24] Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results
    Smolen, Josef S.
    Siebert, Stefan
    Korotaeva, Tatiana, V
    Selmi, Carlo
    Bergmans, Paul
    Gremese, Elisa
    Joven-Ibanez, Beatriz
    Katsifis, Gkikas
    Noel, Wim
    Nurmohamed, Michael T.
    Richette, Pascal
    Sfikakis, Petros P.
    de Vlam, Kurt
    Theander, Elke
    Gossec, Laure
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11) : 1419 - 1428
  • [25] Administration of anti-IL-12 mAb in Crohn's disease patients leads to downmodulation of p40 expression and IL-12/IL-23 derived cytokines
    Fuss, IJ
    Becker, C
    Yang, ZQ
    Groden, C
    Hornung, R
    Nikolaev, A
    Heller, F
    Neurath, M
    Strober, W
    Mannon, PJ
    GASTROENTEROLOGY, 2005, 128 (04) : A118 - A118
  • [26] Efficacy of Ustekinumab-based integrated medicine therapy in patients with symptomatic stricturing Crohn's disease: a multicentre, prospective, observational cohort study
    Liu, J.
    Hu, W.
    Li, S.
    Xu, D.
    Wu, Q.
    Chen, Y.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1262 - I1262
  • [27] USTEKINUMAB IS EFFECTIVE FOR INDUCING CLINICAL, ENDOSCOPIC, AND RADIOGRAPHIC RESPONSE AND REMISSION IN REFRACTORY MODERATE-TO-SEVERE CROHN'S DISEASE: A MULTICENTRE COHORT STUDY
    Ma, Christopher
    Fedorak, Richard N.
    Kaplan, Gilaad
    Dieleman, Levinus A.
    Devlin, Shane M.
    Stern, Nathan
    Kroeker, Karen I.
    Seow, Cynthia H.
    Leung, Yvette
    Novak, Kerri L.
    Halloran, Brendan P.
    Huang, Vivian
    Wong, Karen
    Ghosh, Subrata
    Panaccione, Remo
    GASTROENTEROLOGY, 2017, 152 (05) : S410 - S411
  • [28] HLA-C*06:02 Allele and Response to IL-12/23 Inhibition: Results from the Ustekinumab Phase 3 Psoriasis Program
    Li, Katherine
    Huang, C. Chris
    Randazzo, Bruce
    Li, Shu
    Szapary, Philippe
    Curran, Mark
    Campbell, Kim
    Brodmerkel, Carrie
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (12) : 2364 - 2371
  • [29] Baseline Assessment of Serum Cytokines Predicts Clinical and Endoscopic Response to Ustekinumab in Patients With Crohn's Disease: A Prospective Pilot Study
    Bertani, Lorenzo
    Antonioli, Luca
    Fornili, Marco
    D'Antongiovanni, Vanessa
    Ceccarelli, Linda
    Carmisciano, Luca
    Benvenuti, Laura
    Mumolo, Maria Gloria
    Bottari, Andrea
    Pardi, Veronica
    Baiano Svizzero, Giovanni
    Baglietto, Laura
    De Bortoli, Nicola
    Bellini, Massimo
    Fornai, Matteo
    Costa, Francesco
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (12) : 2449 - 2456
  • [30] HLA-C*06:02 PREDISPOSES TO CLINICAL RESPONSE TO IL-12/23 BLOCKER USTEKINUMAB: RESULTS OF PSORIASIS LONG-TERM TREATMENT
    Testi, Manuela
    Talamonti, Marina
    Andreani, Marco
    Galluccio, Tiziana
    Condello, Rossella
    Stellitano, Chiara
    Chimenti, Sergio
    Galluzzo, Marco
    HLA, 2016, 87 (04) : 234 - 234
12345